Skip to main content
Log in

Applied study of sentinel lymph node biopsy in colorectal cancer

  • Published:
The Chinese-German Journal of Clinical Oncology

Abstract

Objective

The aim of this study was to investigate the feasibility of sentinel lymph node biopsy (SLNB) in colorectal cancer.

Methods

Twenty patients of colorectal cancer were enrolled in this study. Endoscopic injection submucosally of 99mTc-DX was performed around the primary tumor 3 h before operation. Immediately after laparotomy, methylene blue was injected into subserosal layer adjacent to the tumor. Sentinel lymph nodes (SLNs) were defined as blue stained nodes or (and) those containing 10 times more radioactivity than surrounding tissue with a γ probe, all resected nodes were examined postoperatively by routine rapid frozen examination and HE stain. The diagnostic nodes metastasis states and false-negative rate of regional lymph node status on the basis of SLNs were calculated respectively.

Results

SLNs were detected in 16 of 20 patients with a successful detection rate of 80%, the number of SLNs ranged from 1 to 3, with a mean value of 2.4 per case, metastasis rate of SLNs were 37.5% (18/48), the diagnostic sensitivity was 80% (16/20), the diagnostic accuracy was 83.3% (15/18), the false-negative rate was 20% (4/20).

Conclusion

The SLN concept is validated in colorectal cancer. Combined-agent SLN mapping is an accurate diagnostic procedure for detecting lymph node metastasis in patients with colorectal cancer and may indicate rational extent of lymphadenectomy for colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kretschmer L, Hilgers R, Mohrol M, et al. Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease. Eur J Cancer, 2004, 40: 212–218.

    Article  CAS  PubMed  Google Scholar 

  2. Nieweg OE, Bartelink H. Implication of lymphatic mapping for staging adjuvant treatment of patients with breast cancer. Eur J Cancer, 2004, 40: 179–181

    Article  CAS  PubMed  Google Scholar 

  3. Kitagawa Y, Fujii H, Mukai M, et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am, 2000, 80: 1779–1809.

    Article  Google Scholar 

  4. Veronesi U, Pagamelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph node. Lancet, 1997, 349: 1864–1867.

    Article  CAS  PubMed  Google Scholar 

  5. Blichik AJ, Giuliano A, Essner R, et al. Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J Sci Am, 1998, 4: 351–358.

    Google Scholar 

  6. Weaver DL, Krag DN, Ashikaga T, et al. Pathological analysis of sentinel and nonsentinel lymph nodes in breast carcinom: a multicenter study. Cancer, 2000, 88: 1099–1102.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hongwu Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, H., Zhang, H., Yao, H. et al. Applied study of sentinel lymph node biopsy in colorectal cancer. Chin. -Ger. J. Clin. Oncol. 9, 158–160 (2010). https://doi.org/10.1007/s10330-010-0005-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10330-010-0005-y

Key words

Navigation